The synthesis/fabrication core will provide custom chemistry and nanofabrication essential to the success of several research thrust areas. For example, coupling the specificity of monoclonal antibodies to nano dimension features on a sensor chip requires the development of chemical linkers with the requisite specificity. This requires combining the demands of the surface materials chemistry with protein chemistry to prepare linking agents of high purity and selectivity. Expertise in this core area is essential to a wide range of biomedical applications that require binding of enzymes, antibodies, or cells to micro or nanofabricated materials. In addition, the synthesis core will provide expertise in the construction of cationic core shell dendrimers in the 40 - 200 nm range. These nanoparticles will ultimately incorporate drug delivery, imaging, and cell-specific recognition capabilities, which are relavant to a broad range of therapeutic and diagnostic medical applications. Fabrication of nanotechnology devices will be performed at the nanofabrication core, which includes an 11,000 sq ft clean room. It will provide the critical infrastructure for the fabrication of microfluidic structures, and well-controlled, critically shaped, selectively modified micro- and nanostructures. The primary tools will be a complete set of lithographic techniques for compound semiconductor device fabrication, including contact aligners, and an i-line stepper for optical lithography, a JEOL JBX-5DII Electron Beam writer (soon to be augmented by a newer version JEOL e-beam writer). A full range of deposition and etching tools is also included, including the capability to etch very deep channels (~ 100 microns) into silicon and compound semiconductor substrates. For cost effective production, large areas of different chemically functionalized regions could be fabricated on chips through the use of 'chemical stamps', formed from silicon or silicon dioxide. A Nanonex 2000 Nanoimprinter in the facility will allow rapid imprinting of chemical or mechanical patterns onto surfaces as large as 8 inches in diameter. The fabrication core will provide the broad range of micro and nanofabrication, including microfludic interfaces, that are essential for the fabrication of a broad range of practical devices. Characterization and assessment of nanoscale devices will also be carried on within the core or through shared facilities (SEM, TEM, AFM, SIMS) available.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA119335-04
Application #
7688000
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
4
Fiscal Year
2008
Total Cost
$259,832
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Schutt, Carolyn; Ibsen, Stuart; Zahavy, Eran et al. (2017) Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin. Pharm Res 34:2025-2035
Heineck, D P; Lewis, J M; Heller, M J (2017) Electrokinetic device design and constraints for use in high conductance solutions. Electrophoresis 38:1475-1482
Manouchehri, Sareh; Ibsen, Stuart; Wright, Jennifer et al. (2016) Dielectrophoretic recovery of DNA from plasma for the identification of chronic lymphocytic leukemia point mutations. Int J Hematol Oncol 5:27-35
Sandoval, Sergio; Mendez, Natalie; Alfaro, Jesus G et al. (2015) Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform. J Biomed Opt 20:88003
Goodwin, Andrew P; Nakatsuka, Matthew A; Mattrey, Robert F (2015) Stimulus-responsive ultrasound contrast agents for clinical imaging: motivations, demonstrations, and future directions. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:111-23
Campbell, Diahnn F; Saenz, Rebecca; Bharati, Ila S et al. (2015) Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D,L-lactic-co-glycolic) acid nanoparticles. Breast Cancer Res 17:48
Ortac, Inanc; Simberg, Dmitri; Yeh, Ya-san et al. (2014) Dual-porosity hollow nanoparticles for the immunoprotection and delivery of nonhuman enzymes. Nano Lett 14:3023-32
Sonnenberg, Avery; Marciniak, Jennifer Y; Rassenti, Laura et al. (2014) Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood. Clin Chem 60:500-9
Saenz, R; Messmer, B; Futalan, D et al. (2014) Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization. Mol Immunol 57:191-9
Sonnenberg, Avery; Marciniak, Jennifer Y; Skowronski, Elaine A et al. (2014) Dielectrophoretic isolation and detection of cancer-related circulating cell-free DNA biomarkers from blood and plasma. Electrophoresis 35:1828-36

Showing the most recent 10 out of 146 publications